J
József Attila Szász
Researcher at University of Medicine, Pharmacy, Science and Technology of Târgu Mureș
Publications - 29
Citations - 805
József Attila Szász is an academic researcher from University of Medicine, Pharmacy, Science and Technology of Târgu Mureș. The author has contributed to research in topics: Parkinson's disease & Levodopa. The author has an hindex of 9, co-authored 25 publications receiving 609 citations. Previous affiliations of József Attila Szász include University of Pécs.
Papers
More filters
Journal ArticleDOI
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations.
Rupam Borgohain,József Attila Szász,Paolo Stanzione,Chandrashekhar Meshram,Mohit Bhatt,D. Chirilineau,Fabrizio Stocchi,V. Lucini,R. Giuliani,Emma Forrest,P. Rice,R. Anand,M. Illiyas Sahadulla,U. Kardan,B. S. Keshava,A. Kishore,S. S. Kothari,J. M. Krishna Murthy,S. Kumar,P. Kumar Pal,N. Mehta,S. Prabhakar,S. Kr Prabhakar,S. Pradhan,A. K. Roy,C. Sankhla,P. K. Sethi,Amy Shah,N. Shankar,R. Shukla,A. Sowani,R. Srinivasa,M. Varma,D. Vasudevan,P. Vavilikolanu Sreenivas,C. U. Velmurugendran,K. Vijayan,Ovidiu Bajenaru,A. Bulboaca,A. Campeanu,D. Chirileanu,D. Muresanu,C. Panea,C. D. Popescu,Mihaela Simu,M. Ticmeanu,Tania P. Avarello,Ubaldo Bonuccelli,Roberto Eleopra,Marco Onofrj,Rocco Quatrale +50 more
TL;DR: The addition of safinamide 50 mg/day or 100mg/day to l‐dopa in patients with PD and motor fluctuations significantly increased total on time with no or nontroublesome dyskinesia, decreased off time, and improved parkinsonism, indicating thatsafinamide improves motor symptoms and parkinsonistan without worsening dyskineia.
Journal ArticleDOI
Two-Year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
Rupam Borgohain,József Attila Szász,Paolo Stanzione,Chandrashekhar Meshram,Mohit Bhatt,Dana Chirilineau,Fabrizio Stocchi,V. Lucini,R. Giuliani,Emma Forrest,Patricia Rice,R. Anand +11 more
TL;DR: This 2‐year, controlled study of add‐on safinamide in mid‐to‐late Parkinson's disease with motor fluctuations showed improvement in dyskinesia in patients at least moderately dyskinetic at baseline, and demonstrated significant clinical benefits in ON‐time (without troublesome dysKinesia), OFF‐time, activities of daily living, motor symptoms, quality of life, and symptoms of depression.
Journal ArticleDOI
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.
Angelo Antonini,Werner Poewe,K. Ray Chaudhuri,Robert Jech,Barbara A. Pickut,Zvezdan Pirtošek,József Attila Szász,Francesc Valldeoriola,Christian Winkler,Lars Bergmann,Ashley Yegin,Koray Onuk,David,Per Odin,Ene Amalia,Guy Arnold,Ovidiu Bajenaru,Bruno Bergmans,Kari Anne Bjørnarå,Jeff Blackie,Matthias Bode,Paul Bourgeois,Stephan Bohlhalter,Ioan Buraga,Pierre R. Burkhard,Philippe Busson,Matilde Calopa,Jesper Clausen,Erik H. Danielsen,Luc Defebvre,Valérie Delvaux,Sophie Dethy,Espen Dietrichs,Oriol De Fabregues,Ransmayr Gerhard,Graziano Gusmaroli,Kirsten Hahn,Björn Hauptmann,Tove Henriksen,Jorge Hernández-Vara,Anne Jeanjean,Michaela Kaiserová,Jan Kassubek,Thomas E. Kimber,Spyridon Konitsiotis,Rejko Krüger,Rejko Krüger,Jaime Kulisevsky,Jo Leenders,Christofer Lundqvist,F. Ory Magne,Pietro Marano,Ivan Milanov,Nicola Modugno,Anjum Misbahuddin,Martin Nevrly,Zikos Panayiotis,Kenn Freddy Pedersen,Stephen Wørlich Pedersen,Lacramioara Perju-Dumbrava,M.M. Ponsen,Bogdan Ovidiu Popescu,Michel Rijntjes,Víctor Puente,Christoph Redecker,Christoph Schrader,Mariachiara Sensi,Mihaela Simu,Cleanthe Spanaki,Alexander Storch,Anette Storstein,Volker Tomantschger,Chris van der Linden,T. van Laar,F. Viallet,Tatiana Witjas,Martin Wolz,Maurizio Zibetti,Michel Van Zandijcke +78 more
TL;DR: LCIG treatment led to sustained improvements in motor fluctuations, non-motor symptoms particularly sleep/fatigue, mood/cognition and gastrointestinal domains, as well as quality of life in advanced PD patients over 24 months.
Journal ArticleDOI
Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison.
Levente Kerényi,László Kardos,József Attila Szász,Szabolcs Szatmári,Dániel Bereczki,Katalin Hegedüs,László Csiba +6 more
TL;DR: It seems that not serum glucose level but diabetes mellitus in the case history is an independent predictor of HTr, and the multiple model confirmed age in case of embolic stroke, andabetes mellitus and infarct size as independent risk factors of H Tr.
Journal ArticleDOI
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
Ovidiu Bajenaru,A. Ene,Bogdan Ovidiu Popescu,József Attila Szász,M. Sabău,D. F. Mureşan,L. Perju-Dumbrava,C. D. Popescu,A. Constantinescu,I. Buraga,Mihaela Simu +10 more
TL;DR: A significant improvement in PD symptoms after initiation of LCIG therapy was observed and the quantified non-motor symptoms subsided, and patients exhibited significant improvements in QoL scores.